The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
Fiscal Year 2009: The Epidemiology and Laboratory Capacity (ELC) for Infectious Disease program plays a critical role in strengthening our nation s infrastructure for preventing and controlling infectious diseases. The program builds epidemiology, laboratory, and information systems capacity in all 50 states to assist frontline state programs respond to infectious disease outbreaks, address the increasing threat of antimicrobial resistance, and detect and respond to new and emerging infectious diseases. As states are in different stages of implementing laboratory information management systems and electronic laboratory orders and results reporting, ELC funding would be flexible in its applications; however monies would be directed specifically toward meeting the goals of meaningful use for electronic laboratory reporting for nationally notifiable conditions.
As of the end of 2008, 52 of 56 CDC Immunization Program grantees reported that approximately 18 million (75%) U.S. children aged <6 years participated in an Immunization Information System (IIS). Further, only 43% of grantees reported that Health Level 7 (HL7) was used as an electronic format for data received by the IIS while 68% reported the receipt of electronic data using flat file format. Grantees report that many Electronic Health Record (EHR) vendors exchanging data with IIS electronically are already certified by the Certification Commission for Health Information Technology (CCHIT), but not for interoperability with IISs. Direct funding to state and local CDC Immunization Program grantees with IIS will be used to plan, enhance, adopt, and apply health information technology standards for direct health care system interoperability. Enhanced EHR-IIS interoperability will improve the completeness of immunization histories available to clinicians and public health, improve the timeliness of immunization data submission to an IIS, improve the quality of IIS coverage assessments, and the data available to other public health systems (e.g. vaccine preventable disease surveillance units). Improved interoperability will also reduce extra immunization, thereby saving time and resources.
The Laboratory Technical Implementation Center for Public Health (LTICPH) will establish capacity to assist public health laboratories and state health departments to enhance laboratory information management systems (LIMS) and other critical IT infrastructure to support interoperability and sharing of electronic laboratory data with public health agencies and lay the groundwork for interoperability with EHRs. This Center will help labs implement and maintain the capacity to format and electronically share standard data, and public health recipients must be able to securely receive, parse, and use such data. Public health department partners, likewise, must develop and maintain complementary IT infrastructure to securely receive, parse, analyze, and utilize shared data. Electronic laboratory data must be seamlessly incorporated into public health systems to adequately support public health in leveraging laboratory data to ensure a holistic approach to surveillance and to support epidemiological analysis and public health response. Fiscal Year 2010: No Current Data Available Fiscal Year 2011: No Current Data Available
Uses and Use Restrictions
Project funds will be used to improve the interoperability of immunization information systems and electronic laboratory information exchange between public health and clinical care.
Of the HITECH funds that CDC will provide 85% of the funds to eligible states/territories/large local health departments, non-governmental organizations, or not-for-profit organizations using the following Cooperative Agreements: the Epidemiology and Laboratory Capacity for Infectious Disease program, the Laboratory Technical Implementation Assistance for Public Health and the CDC State Immunization Program.
Project funds may be used for costs associated with planning, organizing, conducting and supporting programs directed toward meeting meaningful use objectives related to the interoperability of immunization registries with Electronic Health Records (EHR) and electronic laboratory information exchange between public health and clinical care.
These funds may be used for the preservation of jobs necessary to build capacity in state and local health departments related to these program areas.
CDC will provide 85% of the funds to eligible states/territories/large local health departments, non-governmental organizations, or not-for-profit organizations using the following Cooperative Agreements: the Epidemiology and Laboratory Capacity for Infectious Disease program, the Laboratory Technical Implementation Assistance for Public Health and the CDC State Immunization Program.
Eligible applicants for grants and cooperative agreements are public health departments that are recipients of Section 317 grantees, Epidemiology and Laboratory Capacity cooperative agreements recipients, or Nonprofit with 501C3 IRS status (other than institution of higher education), Nonprofit without 501C3 IRS status (other than institution of higher education), For-profit organizations (other than small business), Small, minority, and women-owned businesses, Universities, Colleges, Research institutions, Hospitals, Community-based organizations, Faith-based organizations, Federally recognized or state-recognized American Indian/Alaska Native tribal governments, American Indian/Alaska native tribally designated organizations, Alaska Native health corporations, Urban Indian health organizations, Tribal epidemiology centers, State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau), Political subdivisions of States (in consultation with States).
State/territory/large local health departments for two cooperative agreements and open competition for one cooperative agreement,.
Applicants should review the individual CDC Guidance documents issued under specific Funding Opportunity Announcement (FOAs) for this CFDA program for any required proof or certifications which must be submitted prior to or simultaneous with submission of an application package. OMB Circular No. A-87 applies to this program.
Aplication and Award Process
Applicants must download the SF424 (R&R) application forms and SF424 (R&R) Application Guide for this requirement through Grants.gov/Apply.
Only the forms package directly attached to a specific Funding Opportunity Announcement (FOA) can be used.
Applicants will not be able to use any other SF424 (R&R) forms (e.g., sample forms, forms from another FOA) although some of the.
Environmental impact information is not required for this program.
This program is excluded from coverage under E.O.
OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. Applicants must download the SF424 (R&R) application forms and SF424 (R&R) Application Guide for this requirement through Grants.gov/Apply.
Only the forms package directly attached to a specific Funding Opportunity Announcement (FOA) can be used. Applicants will not be able to use any other SF424 (R&R) forms (e.g., sample forms, forms from another FOA) although some of the "Attachment" files may be useable for more than one FOA.
If an applicant does not have access to the Internet, or if they have difficulty accessing the forms online, contact the CDC Procurement and Grants Office Technical Information Management Section (PGOTIMS) staff. For this, or further assistance, contact PGO TIMS: Telephone (770) 488-2700, Email: PGOTIM@cdc.gov.
HHS/CDC Telecommunications for the hearing impaired: TTY 770-488-2783.
The standard application forms must be used for this program, as furnished by CDC and required by 45 CFR 92 for State and local governmental agencies, and by 45 CFR 74 for nongovernmental applicants. This program is subject to the provisions of 45 CFR 92 for State and local governments and 45 CFR 74 for nonprofit organizations.
Applications that are complete and responsive to competitive new grant and cooperative agreement announcements will undergo an objective review process, receive a written critique and be scored according to published review criteria. Successful applicants will receive a Notice of Award (NOA) from the CDC Procurement and Grants Office. The NOA shall be the only binding, authorizing document between the recipient and CDC. The NOA will be signed by an authorized Grants Management Officer.
Contact the headquarters or regional office, as appropriate, for application deadlines.
American Recovery and Reinvestment Act of 2009, Public Law 111-5.
Range of Approval/Disapproval Time
From 90 to 120 days.
Renewals will be based upon availability of funding under the American Recovery and Reinvestment Act.
Formula and Matching Requirements
This program has no statutory formula.
This program has no matching requirements.
MOE requirements are not applicable to this program.
Length and Time Phasing of Assistance
After Notices of Grant Award are issued, funds are released in accordance with HHS payment procedures, which may be through an Electronic Transfer System or a Monthly Cash Request System. Project period: up to two years. Method of awarding/releasing assistance: by letter of credit.
Post Assistance Requirements
Program reports are not applicable.
Cash reports are not applicable.
Recipients of Federal awards from funds authorized under Division A of the ARRA must comply with all requirements specified in Division A of the ARRA (Public Law 111-5), including reporting requirements outlined in Section 1512 of the Act.
For purposes of reporting, ARRA recipients must report on ARRA sub-recipient (sub-grantee and sub-contractor) activities as specified below.
Not later than 10 days after the end of each calendar quarter, starting with the quarter ending June 30, 2009 and reporting by July 10, 2009, the recipient must submit quarterly reports to HHS that will posted to Recovery.gov, containing the following information:
The total amount of ARRA funds under this award;
The amount of ARRA funds received under this award that were obligated and expended to projects or activities;
The amount of unobligated award balances;
A detailed list of all projects or activities for which ARRA funds under this award were obligated and expended, including: (1) the name of the project or activity; (2) a description of the project or activity; (3) an evaluation of the completion status of the project or activity; (4) an estimate of the number of jobs created and the number of jobs retained by the project or activity; and (5) for infrastructure investments made by State and local governments, the purpose, total cost, and rationale of the agency for funding the infrastructure investment with funds made available under this Act, and the name of the person to contact at the agency if there are concerns with the infrastructure investment.
Detailed information on any sub-awards (sub-contracts or sub-grants) made by the grant recipient to include the data elements required to comply with the Federal Funding Accountability and Transparency Act of 2006 (Public Law 109-282).
For any sub-award equal to or larger than $25,000, the following information will be required: (1) the name of the entity receiving the sub-award; (2) the amount of the sub-award; (3) the transaction type; (4) the North American Industry Classification System code or Catalog of Federal Domestic Assistance (CFDA) number; (5) program source; (6) an award title descriptive of the purpose of each funding action; (7) the location of the entity receiving the award; (8) the primary
location of performance under the award, including the city, State, congressional
district, and country; and (9) a unique identifier of the entity receiving the award
and of the parent entity of the recipient, should the entity be owned by another
All sub-awards less than $25,000 or to individuals may be reported in the aggregate, as prescribed by HHS.
Recipients must account for each ARRA award and sub-award (sub-grant and sub-contract) separately.
Recipients will draw down ARRA funds on an award-specific basis.
Pooling of ARRA award funds with other funds for drawdown or other purposes is not permitted.
Recipients must account for each ARRA award separately by referencing the assigned CFDA number for each award.
Additional reporting requirements will be detailed in Funding Opportunity Announcements and included in award notices.
Final financial status and performance reports are required 90 days after the end of the project period.
Expenditure reports are not applicable.
See reporting under progress reports above.
In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. The audit must be completed along with a data collection form, and the reporting package shall be submitted within the earlier of 30 days after receipt of the auditors report(s), or 9 months after the end of the audit period. The audit report must be sent to: Federal Audit Clearing House, Bureau of the Census, 1201 East 10th Street, Jeffersonville, IN 47132. Should you have questions regarding the submission or processing of your Single Audit Package, contact the Federal Audit Clearinghouse at: (301) 763-1551, (800) 253-0696 or e-mail: email@example.com The grantee is to ensure that the sub-recipients receiving CDC funds also meet these requirements (if total Federal grant or grant funds received exceed $500,000). The grantee must also ensure that appropriate corrective action is taken within 6 months after receipt of the sub-recipient audit report in instances of non-compliance with Federal law and regulations. The grantee is to consider whether sub-recipient audits necessitate adjustment of the grantees own accounting records. If a sub-recipient is not required to have a program-specific audit, the Grantee is still required to perform adequate monitoring of sub-recipient activities. The grantee is to require each sub-recipient to permit independent auditors to have access to the sub-recipients records and financial statements. The grantee should include this requirement in all sub-recipient contracts.
Financial records, supporting documents, statistical records, and all other records pertinent to the grant program shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with 45 CFR 92.42 requirements or 45 CFR 74.53, accordingly to the type of recipient.
(Cooperative Agreements (Discretionary Grants)) FY 09 $0; FY 10 est $24,300,000; FY 11 est $0
Range and Average of Financial Assistance
Range of awards will be $100,000 to $5,000,000.
Regulations, Guidelines, and Literature
This program is subject to the provisions of 45 CFR Part 92 for State, local and tribal governments and 45 CFR Part 74 for institutions of higher education, hospitals, other nonprofit organizations and commercial organizations.
Regional or Local Office
Laura Conn NCPHI, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road, NE., Mailstop E85, Atlanta, Georgia 30333 Email: LConn@cdc.gov Phone: 404-639-2475
Criteria for Selecting Proposals
Criteria for selecting applications are available in the funding opportunity announcement guidance document. In addition, all applicants are expected to demonstrate compliance with applicable program requirements. Applicants are strongly encouraged to demonstrate compliance with these requirements and expectations in the application. Applicants requesting funding under multiple programs are expected to demonstrate compliance with the expectations and requirements for all of those programs.
Morgan Stanley Institute for Sustainable Investing, in a collaborative venture with the Kellogg School of Management at Northwestern University and INSEAD, launches its latest Sustainable Investing Challenge.